|Articles|May 2, 2016
- Pharmaceutical Technology-05-02-2016
- Volume 40
- Issue 5
Ultracentrifuge Allows for Multi-Wavelength Analysis
The Optima AUC from Beckman Coulter Life Sciences is an ultracentrifuge that determines molecular weight, size shape, and polydispersity.
The Optima AUC from Beckman Coulter Life Sciences is an ultracentrifuge that determines molecular weight, size shape, and polydispersity. The Optima AUC has a 38.1-cm (15-inch diagonal) touch-screen with the ability to export data locally or remotely. The optics are contained outside the rotor chamber, reducing the impact of the g-force on the optics. The Optima AUC also allows molecules to float free and unbound so that researchers are able to characterize them in their native state. The ultracentrifuge can perform multi-wavelength analysis and allows for the development of new detection systems.
Articles in this issue
almost 10 years ago
Forced Degradation Studies for Biopharmaceuticalsalmost 10 years ago
Choosing Containment Strategies For Highly Potent APIsalmost 10 years ago
Visions for the Future of Biopharma Manufacturingalmost 10 years ago
Outsourcing of Biomanufacturing in 2016almost 10 years ago
Pharmaceutical Quality: Where Do We Need to Go from Here?almost 10 years ago
Reporting Quality Metrics to FDAalmost 10 years ago
Significant Revisions and Updates to the European Pharmacopoeiaalmost 10 years ago
Upstream and Downstream Operations Can Impact Biologic API Uniformityalmost 10 years ago
The Value of Saving LivesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
2
Women in STEM: Early Phase Drug Development
3
Rare Disease Treatments: Navigating the Economics of Global Innovation
4
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
5